Zhengye Biotechnology (ZYBT) Stock Analysis: AI Score & Alternative Data
Zhengye Biotechnology — alt-data steady across 90 days
Is Zhengye Biotechnology a buy right now? The alternative data says hold. This ZYBT stock analysis is built on the 25+ alternative data signals AltIndex tracks on Zhengye Biotechnology every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 49/100: a Hold. The stock trades at $1.61 with a $61M market cap.
No core signal has moved more than 5% in 90 days — steady, but without the momentum that pushes a stock into buy territory.
ZYBT’s broader alt-data profile also covers web traffic (193 monthly visits), and sentiment (89/100). Every signal links to its own page with full history, the ZYBT technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on ZYBT is just below.
Zhengye Biotechnology AI Stock Analysis
Zhengye Biotechnology is a prominent player in the biopharmaceutical industry, focusing on innovative biotechnological solutions. The company specializes in the research, development, and production of high-quality bio-products that cater to diverse health needs.
Analysis generated August 1, 2026.
Recent Zhengye Biotechnology Stock Alerts
|
Zhengye Biotechnology | August 11 Price is down by -6.1% in the last 24h. |
|
Zhengye Biotechnology | August 7 Price is up by 13.9% in the last 24h. |
|
Zhengye Biotechnology | August 6 Price is down by -12.7% in the last 24h. |
|
Zhengye Biotechnology | August 5 Price is up by 11.7% in the last 24h. |
Zhengye Biotechnology Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 193 | N/A | |
| Sentiment | 89 | N/A | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 1 | N/A | |
| Stocktwits Mentions | 586 | N/A | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 876 | N/A |
About Zhengye Biotechnology (ZYBT)
Zhengye Biotechnology Holding Limited (Ticker: ZYBT) is an innovative biotechnology firm specializing in the development and commercialization of advanced biopharmaceutical products aimed at addressing critical medical needs. With a robust pipeline and proprietary technologies, ZYBT is well-positioned to enhance treatment outcomes across multiple therapeutic areas. The company's commitment to rigorous research and development, coupled with a focus on quality and innovation, underscores its potential for sustainable growth and value creation for investors in the competitive biotechnology landscape.
| Price | $1.61 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $61M |
| Year Range | $1 – $2 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Drug Manufacturers |
Latest Zhengye Biotechnology News
View more →| No recent news for ZYBT. |
Zhengye Biotechnology Earnings & Financial Performance
View all earnings →Zhengye Biotechnology Insider Trading Activity
View all →| No recent insider transactions on file. |
Zhengye Biotechnology Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Zhengye Biotechnology
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
CleneCLNN |
$4.37 15.3% | $66M | 42 |
 |
Scilex HoldingSCLX |
$6.71 0.3% | $47M | 40 |
 |
Mira PharmaceuticalsMIRA |
$0.78 1.4% | $32M | 54 |
 |
TherapeuticsMDTXMD |
$2.07 0.0% | $24M | 44 |
 |
Apimeds PharmaceuticalsAPUS |
$4.63 9.2% | $6M | 44 |
Explore Zhengye Biotechnology Data
Frequently Asked Questions: Zhengye Biotechnology (ZYBT)
Zhengye Biotechnology has an AltIndex AI Score of 49/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
49/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Zhengye Biotechnology (ZYBT) stock is $1.61 with a market cap of $61M.
As of today, Zhengye Biotechnology’s PE (Price to Earnings) ratio is —.
View the latest Zhengye Biotechnology insider transactions to see recent buying and selling activity by company executives and directors.
Check the Zhengye Biotechnology congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The ZYBT stock price chart above shows Zhengye Biotechnology’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Zhengye Biotechnology technical analysis for RSI, moving averages, and more.
See the stocks similar to Zhengye Biotechnology section on this page for companies in the same industry ranked by market cap and AI Score.
